Compounds > nylidrin
Page last updated: 2024-11-01

nylidrin and Diabetes Mellitus

nylidrin has been researched along with Diabetes Mellitus in 2 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BECKMANN, W1
Karpman, HL1
Okun, R1

Trials

1 trial available for nylidrin and Diabetes Mellitus

ArticleYear
The effect of vasodilating drugs in peripheral vascular disease.
    Geriatrics, 1972, Volume: 27, Issue:11

    Topics: Aged; Arteriosclerosis Obliterans; Cardiac Output; Clinical Trials as Topic; Diabetes Mellitus; Diab

1972

Other Studies

1 other study available for nylidrin and Diabetes Mellitus

ArticleYear
[Dilatol therapy in cardio-vascular complications of diabetes mellitus].
    Zeitschrift fur klinische Medizin, 1951, Apr-15, Volume: 2, Issue:7-8

    Topics: Diabetes Complications; Diabetes Mellitus; Heart; Humans; Nylidrin

1951